Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies

Jennifer L. Crombie, Amy C. Sherman, Chi-An Cheng, Christine E. Ryan, Rebecca Zon, Michaël Desjardins, Peter Baker, Mikaela McDonough, Natalie Izaguirre, Bruce Bausk, Jonathan Krauss, Tal Gilboa, Yasmeen Senussi, David R. Walt, Matthew S. Davids, Jennifer R. Brown, Philippe Armand, Lindsey R. Baden, Nicolas Issa

Blood Adv (2021) 5 (16): 3062–3065.

https://doi.org/10.1182/bloodadvances.2021005328

Published: 2021

Journal Articles

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, Y. Tabib, Y. C. Cohen, N. Benyamini, O. Beyar-Katz, M. Neaman, R. Vitkon, N. Keren-Khadmy, M. Levin, Y. Herishanu, I. Avivi

Blood Adv (2021) 5 (16): 3053–3061.

https://doi.org/10.1182/bloodadvances.2021005094

Published: 2021

Journal Articles

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia

Stavroula Ntoufa, Marina Gerousi, Stamatia Laidou, Fotis Psomopoulos, Georgios Tsiolas, Theodoros Moysiadis, Nikos Papakonstantinou, Larry Mansouri, Achilles Anagnostopoulos, Niki Stavrogianni, Sarka Pospisilova, Karla Plevova, Antonios M. Makris, Richard Rosenquist, Kostas Stamatopoulos

Blood Adv (2021) 5 (13): 2788–2792.

https://doi.org/10.1182/bloodadvances.2020001717

Published: 2021

Includes: Supplemental data

Journal Articles

A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C)

Saravanan Subramaniam, Yamini Ogoti, Irene Hernandez, Mark Zogg, Fady Botros, Robert Burns, Jacob T. DeRousse, Chris Dockendorff, Nigel Mackman, Silvio Antoniak, Craig Fletcher, Hartmut Weiler

Blood Adv (2021) 5 (13): 2760–2774.

https://doi.org/10.1182/bloodadvances.2021004360

Published: 2021

Includes: Supplemental data

Journal Articles

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Manjola Balliu, Laura Calabresi, Niccolò Bartalucci, Simone Romagnoli, Laura Maggi, Rossella Manfredini, Matteo Lulli, Paola Guglielmelli, Alessandro Maria Vannucchi

Blood Adv (2021) 5 (8): 2184–2195.

https://doi.org/10.1182/bloodadvances.2020003291

Published: 2021

Includes: Supplemental data

Journal Articles

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

Blake S. Moses, Samantha McCullough, Jennifer M. Fox, Bryan T. Mott, Søren M. Bentzen, MinJung Kim, Jeffrey W. Tyner, Rena G. Lapidus, Ashkan Emadi, Michelle A. Rudek, Tami J. Kingsbury, Curt I. Civin

Blood Adv (2021) 5 (3): 711–724.

https://doi.org/10.1182/bloodadvances.2020003429

Published: 2021

Includes: Supplemental data

Journal Articles

Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy

Aaron J. Wilk, Nancy Lynn-Benner Weidenbacher, Rosemary Vergara, Ole A. W. Haabeth, Ronald Levy, Robert M. Waymouth, Paul A. Wender, Catherine A. Blish

Blood Adv (2020) 4 (17): 4244–4255.

https://doi.org/10.1182/bloodadvances.2020002355

Published: 2020

Includes: Supplemental data

Journal Articles

Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice

Stéphane Chappaz, Charity W. Law, Mark R. Dowling, Kirstyn T. Carey, Rachael M. Lane, Linh H. Ngo, Vihandha O. Wickramasinghe, Gordon K. Smyth, Matthew E. Ritchie, Benjamin T. Kile

Blood Adv (2020) 4 (7): 1270–1283.

https://doi.org/10.1182/bloodadvances.2019001323

Published: 2020

Includes: Supplemental data

Journal Articles

The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models

Yousef Salama, Andries Hendrik Heida, Kazuaki Yokoyama, Satoshi Takahashi, Koichi Hattori, Beate Heissig

Blood Adv (2020) 4 (6): 1021–1037.

https://doi.org/10.1182/bloodadvances.2019001002

Published: 2020

Includes: Supplemental data

Journal Articles

High level of fetal-globin reactivation by designed transcriptional activator-like effector

Jun Zhan, Maria Johnson Irudayam, Yukio Nakamura, Ryo Kurita, Arthur W. Nienhuis

Blood Adv (2020) 4 (4): 687–695.

https://doi.org/10.1182/bloodadvances.2019000482

Published: 2020

Includes: Supplemental data

Journal Articles

BCL2L1 is associated with γ-globin gene expression

Yan Dai, Elmutaz M. Shaikho, Jessica Perez, Carolyn A. Wilson, Lesley Y. Liu, Mitchell R. White, John J. Farrell, David H. K. Chui, Paola Sebastiani, Martin H. Steinberg

Blood Adv (2019) 3 (20): 2995–3001.

https://doi.org/10.1182/bloodadvances.2019032243

Published: 2019

Journal Articles

STAT3β is a tumor suppressor in acute myeloid leukemia

Petra Aigner, Tatsuaki Mizutani, Jaqueline Horvath, Thomas Eder, Stefan Heber, Karin Lind, Valentin Just, Herwig P. Moll, Assa Yeroslaviz, Michael J. M. Fischer, Lukas Kenner, Balázs Győrffy, Heinz Sill, Florian Grebien, Richard Moriggl, Emilio Casanova, Dagmar Stoiber

Blood Adv (2019) 3 (13): 1989–2002.

https://doi.org/10.1182/bloodadvances.2018026385

Published: 2019

Includes: Supplemental data

Journal Articles

The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells

Xianjiang Lan, Eugene Khandros, Peng Huang, Scott A. Peslak, Saurabh K. Bhardwaj, Jeremy D. Grevet, Osheiza Abdulmalik, Hongxin Wang, Cheryl A. Keller, Belinda Giardine, Josue Baeza, Emily R. Duffner, Osama El Demerdash, Xiaoli S. Wu, Christopher R. Vakoc, Benjamin A. Garcia, Ross C. Hardison, Junwei Shi, Gerd A. Blobel

Blood Adv (2019) 3 (10): 1586–1597.

https://doi.org/10.1182/bloodadvances.2019032318

Published: 2019

Includes: Supplemental data

Journal Articles

Dysregulated megakaryocyte distribution associated with nestin + mesenchymal stem cells in immune thrombocytopenia

Min Wang, Ru Feng, Jia-min Zhang, Lin-lin Xu, Fei-er Feng, Chen-cong Wang, Qian-ming Wang, Xiao-lu Zhu, Yun He, Jing Xue, Hai-xia Fu, Meng Lv, Yuan Kong, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu, Xiao-jun Huang, Xiao-hui Zhang

Blood Adv (2019) 3 (9): 1416–1428.

https://doi.org/10.1182/bloodadvances.2018026690

Published: 2019

Includes: Supplemental data

Journal Articles

Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia

Heiko Becker, Gabriele Greve, Keisuke Kataoka, Jan-Philipp Mallm, Jesús Duque-Afonso, Tobias Ma, Christoph Niemöller, Milena Pantic, Justus Duyster, Michael L. Cleary, Julia Schüler, Karsten Rippe, Seishi Ogawa, Michael Lübbert

Blood Adv (2019) 3 (5): 761–765.

https://doi.org/10.1182/bloodadvances.2018023879

Published: 2019

Includes: Supplemental data

Journal Articles

Ablation of miR-146b in mice causes hematopoietic malignancy

Takahiro Mitsumura, Yoshiaki Ito, Tomoki Chiba, Takahide Matsushima, Ryota Kurimoto, Yoko Tanaka, Tomomi Kato, Keisuke Uchida, Takashi Ito, Kouhei Yamamoto, Yoshinobu Eishi, Masanobu Kitagawa, Yasunari Miyazaki, Naohiko Inase, Hiroshi Asahara

Blood Adv (2018) 2 (23): 3483–3491.

https://doi.org/10.1182/bloodadvances.2018017954

Published: 2018

Includes: Supplemental data

Journal Articles

Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia

Coline Gaillard, Sangeetha Surianarayanan, Trevor Bentley, Matthew R. Warr, Briana Fitch, Huimin Geng, Emmanuelle Passegué, Hugues de Thé, Scott C. Kogan

Blood Adv (2018) 2 (19): 2462–2466.

https://doi.org/10.1182/bloodadvances.2018018929

Published: 2018

Includes: Supplemental data

Journal Articles

Single-cell heterogeneity in Sézary syndrome

Blood Adv (2018) 2 (16): 2115–2126.

https://doi.org/10.1182/bloodadvances.2018022608

Published: 2018

Includes: Supplemental data

Journal Articles

The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance

Ahmad H. Mufti, Kenichi Ogiwara, Laura L. Swystun, Jeroen C. J. Eikenboom, Ulrich Budde, Wilma M. Hopman, Christer Halldén, Jenny Goudemand, Ian R. Peake, Anne C. Goodeve, David Lillicrap, Daniel J. Hampshire

Blood Adv (2018) 2 (13): 1585–1594.

https://doi.org/10.1182/bloodadvances.2017011643

Published: 2018

Includes: Supplemental data

Journal Articles

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, Siv Helen Moen, Kristine Misund, Katarzyna Maria Psonka-Antonczyk, Mariaserena Giliberto, Glenn Buene, Anders Sundan, Anders Waage, Anne-Marit Sponaas, Therese Standal

Blood Adv (2017) 1 (27): 2656–2666.

https://doi.org/10.1182/bloodadvances.2017010801

Published: 2017

Includes: Supplemental data

NARROW

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia

A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C)

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy

Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice

The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models

High level of fetal-globin reactivation by designed transcriptional activator-like effector

BCL2L1 is associated with γ-globin gene expression

STAT3β is a tumor suppressor in acute myeloid leukemia

The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells

Dysregulated megakaryocyte distribution associated with nestin + mesenchymal stem cells in immune thrombocytopenia

Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia

Ablation of miR-146b in mice causes hematopoietic malignancy

Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia

Single-cell heterogeneity in Sézary syndrome

The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only